As concern over per‐ and polyfluoroalkyl substances (PFAS) builds, so does the surge of regulatory actions aimed at controlling these compounds. Early adoption of PFAS capture and destruction methods positions dischargers to manage these challenges more effectively.
Mrasek et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: